<DOC>
	<DOCNO>NCT00092911</DOCNO>
	<brief_summary>The main objective study compare antidepressant efficacy safety DVS-233 SR versus placebo adult outpatient Major Depressive Disorder .</brief_summary>
	<brief_title>Study Evaluating DVS-233 SR Adult Outpatients With Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Outpatients Men woman age 18 year age old Women childbearing potential participating study must negative serum pregnancy test result screen use medically acceptable form contraception Treatment DVS233 SR time past Treatment venlafaxine ( immediate release [ IR ] extend release [ ER ] ) within 90 day study day 1 Known hypersensitivity venlafaxine ( IR ER ) Significant risk suicide base clinical judgment , include common</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>